Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Pittsburgh, Pennsylvania 15213


Purpose:

This research will be conducted to determine whether risk factors exist for piperacillin/tazobactam resistance in ESBL organisms.


Study summary:

This is chart review at UPMC. NO human subject interaction will occur.


Criteria:

Inclusion Criteria: - Clinical information is collected by chart review of "case" and "control" patients. - A "case A" patient is defined as follows: One or more clinical cultures are positive for an ESBL producing bacteria and the organism is piperacillin/tazobactam resistant. - A "case B" patient is defined as follows: One or more clinical cultures are positive for an ESBL producing bacteria and the organism is piperacillin/tazobactam susceptible. - Additionally, 1 control patient in the hospital at the same time as the case patients will be randomly selected for each case and are not in either case group. Exclusion Criteria: - Patients < 18 years of age


NCT ID:

NCT00573521


Primary Contact:

Principal Investigator
Brian Potoski, Pharm D
University of Pittsburgh


Backup Contact:

N/A


Location Contact:

Pittsburgh, Pennsylvania 15213
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.